Try our Advanced Search for more refined results
October 10, 2008
Track this case
Peter G. Sheridan
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.Additional or older documents may be available in Pacer.
A federal judge has shot down Mylan Pharmaceuticals Inc.'s bid to manufacture a generic version of Novartis Pharmaceuticals Corp.'s anti-cholesterol drug Lescol, ruling that a patent covering the treatment is enforceable.
Already a subscriber? Click here to login